Jonathan Seltzer, M.D., MBA, MA, FACC, is an employee and stockholder of ACI Clinical. He is not a member of any speakers’ bureaus and has declared no research funding. Although he receives no direct remuneration, as part of his employment with ACI, he consults in the area of safety, study design, DSMBs and CECs with American Gastroenterological Association, AstraZeneca, Biogen Idec, Boehringer Ingelheim, The Drugs for Neglected Diseases Initiative, Isis Pharmaceuticals, Janssen Research & Development, Main Line Health System, Millennium Pharmaceuticals, Pfizer, Sanofi, SK Life Science, and W.L. Gore & Associates.